Replies to post #48082 on Tauriga Sciences Inc (fka TAUG)

[Johnny_C]

Sounds more like an opinion. Plus, I like the balance sheet and the portfolio. Plus I have stated time and time again that we would put money into taug if they needed it for a good opportunity.

This product is great right now, I would expect the profits to cover the quarterly burn and more because of all the interest in natural products that help with inflammation, pain management, insomnia and more. I think CBD works differently in different people put trying it is for minor ailments is preferable to prescriptions.

Good luck

[Blutribe]

TAUG oversold here .07 last high .36 on 3/14..last news ...Tauriga Sciences, Inc. Enters into Distribution Agreement Focused on Tauri-Gum Sales Throughout Northeast Region of USA and Asia
GlobeNewswire•May 1, 2019
NEW YORK, NY, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced the execution of a Distribution Agreement (the “Agreement”) with a New Jersey based firm with extensive relationships throughout the Northeast region of the USA (“Northeast USA”) and Asia. This is the third distinct major Distribution agreement that the Company has entered into during April of 2019. The thrust of this agreement is to accelerate the market penetration of Tauri-GumTM throughout the Northeast USA as well as Asia. The Company has already received multiple Purchase Orders emanating from this Agreement and has also commenced discussions for a major China based E-Commerce opportunity.

In other news, the Company is pleased to confirm that it has fully paid for the entirety of its 4 Tauri-GumTM production runs; totaling 35,000 Mint flavor blister packs (3,500 Mint flavor retail boxes). Separately, the Company continues to fund its Research & Development initiatives and believes that product innovation is crucial to its long-term success.

ABOUT TAURIGA SCIENCES, INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-GumTM. See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.

In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-GumTM commercialization strategy. This site can be accessed by visiting the following URL address: www.taurigum.com